"Diopsys, Inc. has launched the new Diopsys NOVA-DN VEP Vision Testing System to help optometrists and ophthalmologists detect optic nerve disease, including glaucoma and other neuro-visual disorders," says a company press release. With the system, clinicians reportedly came assess optic nerve disease earlier than traditional vision tests. The system is said to use Visual Evoked Potential (VEP) technology and proprietary software to evaluate the entire vision system from the eye to the visual cortex.
No comments:
Post a Comment